Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orlistat vs Placebo for Body Composition
NCT00752726Phase 4Completed
- Sponsor
- GSK
- Start
- Sep 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial in obesity and Overweight comparing Orlistat with Placebo (2 arms). Primary endpoint: Change From Baseline to Week 24 in Abdominal Visceral Adipose Tissue Mass. Started Sep 2008; status: completed.
02
Drugs
orlistat
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT00752726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00752726.